Heron Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

SAN DIEGO, Nov. 1, 2022 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the…

Click here to view original post